Completed
PHASE2
INTERVENTIONAL
NCT00672074
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
Detailed Description
The safety and efficacy of ipamorelin in the management of post-operative ileus
Interventions
Name:
Ipamorelin
Type:
DRUG
Description:
IV
Name:
placebo
Type:
DRUG
Description:
IV
Primary Outcomes
Measure:
Recovery of GI function
TimeFrame:
Until hospital discharge
Description:
Trial Information
NCT ID
NCT00672074
Status
Completed
Study Type
INTERVENTIONAL
Phases
PHASE2
Sponsor
Helsinn Therapeutics (U.S.), Inc
Last Updated
December 15, 2025